Publications
-
Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF,
Liang Y, Zhou NN, Zhang DS, Wu HY.
Intern Med J.
2013;
43
(1):
73-6
-
Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients.
Ma H,
Wu Y, Lin Y, Cai Q, Ma G, Liang Y.
Eur J Radiol.
2013
-
Esophageal carcinosarcoma: a unique entity with better prognosis.
Wang L,
Lin Y, Long H, Liu H, Rao H, He Y, Rong T, Liang Y.
Ann Surg Oncol.
2013;
20
(3):
997-1004
-
Primary lymphoepithelioma-like carcinoma of ocular adnexa: clinicopathologic features and treatment.
Qiu B,
Lin YB, Cai QQ, Hu YM, Wang DF, Lin ZD, Liang Y.
Curr Oncol.
2013;
20
(2):
e113-22
-
Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma.
Chen C,
Wang FH, An X, Luo HY, Wang ZQ, Liang Y, Zhang L, Li YH.
Cancer Chemother Pharmacol.
2013;
71
(2):
371-8
-
Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
Zeng YD,
Zhang L, Liao H, Liang Y, Xu F, Liu JL, Dinglin XX, Chen LK.
Asian Pac J Cancer Prev.
2012;
13
(3):
909-14
-
Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
Liang Y,
Wang L, Zhu Y, Lin Y, Liu H, Rao H, Xu G, Rong T.
Cancer.
2012;
118
(19):
4748-58
-
Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.
Chen LK,
Liang Y, Yang QY, Xu F, Zhou NN, Xu GC, Liu GZ, Wei WD.
Asian Pac J Cancer Prev.
2012;
13
(5):
1863-7
-
Treatment strategies and prognostic factors of patients with primary germ cell tumors in the mediastinum.
Liu TZ,
Zhang DS, Liang Y, Zhou NN, Gao HF, Liu KJ, Wu HY.
J Cancer Res Clin Oncol.
2011;
137
(11):
1607-12
-
[Prophylactic irradiation at the level Ib for nasopharyngeal carcinoma: should that be a routine?].
Tan JM,
Liang Y, Zhao C, Li MY, Liu JJ.
Nan Fang Yi Ke Da Xue Xue Bao.
2011;
31
(12):
1989-92
-
[A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].
Hu X,
Bao Y, Zhang L, Cheng Y, Li K, Wang W, Liu Y, He H, Sun Z, Zhuang T, Wang Y, Chen J, Liang Y, Zhang Y, Zhao H, Wang F, Chen M.
Zhongguo Fei Ai Za Zhi.
2010;
13
(7):
691-9
-
[Brain radiotherapy combined with sequential chemotherapy in non-small-cell lung cancer patients with brain metastases.].
Chen L,
Yang Q, Liang Y, Liu G, Liao H, Xu G.
Zhongguo Fei Ai Za Zhi.
2009;
12
(8):
896-900
-
[Weekly Paclitaxel and Cisplatin in the Treatment of Elderly Advanced Non-small Cell Lung Cancer.].
Liang Y,
Chen L, Lin Y, Yang Q, Wang Z, Xu G.
Zhongguo Fei Ai Za Zhi.
2009;
12
(10):
1101-5
-
[A prospective randomized study of adjuvant chemotherapy in completely resected stage IIIA-N2 non-small cell lung cancer].
Wang S,
Rong T, Ou W, Lin Y, Liang Y, Ye X.
Zhongguo Fei Ai Za Zhi.
2006;
9
(5):
434-8
-
[Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK,
Xu GC, Liang Y, Yang QY, Zhang LN.
Ai Zheng.
2006;
25
(4):
505-8
-
[Paclitaxel and cisplatin combined with etoposide chemotherapy in non-small cell lung cancer with brain metastases].
Yang QY,
Chen LK, Xu GC, Liu JL, Liang Y, Zhang LN.
Ai Zheng.
2004;
23
(11 Suppl):
1459-62
-
[Concomitant whole brain radiotherapy and FUDR+VM-26+DDP chemotherapy in brain metastasis of non-small cell lung cancer: a report of short term efficacy].
Liu J,
Liu G, Xu G, Chen L, Liang Y.
Zhongguo Fei Ai Za Zhi.
2003;
6
(5):
371-4
-
[Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer].
Chen LK,
Xu GC, Liu GZ, Liang Y, Liu JL, Zhou XM.
Ai Zheng.
2003;
22
(4):
407-10
-
[Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
Chen LK,
Xu GC, Teng XY, Liang Y, Liu JL, Zhou XM.
Ai Zheng.
2002;
21
(8):
903-6